期刊文献+

人分化抑制蛋白1慢病毒干扰载体的构建、筛选及其沉默效应的鉴定

Construction, Screening, and Verifi cation of The Silencing Effects for Human Interference Lentiviral Vector of Inhibitor of Differentiation-1
原文传递
导出
摘要 目的探索以小干扰RNA(si RNA)慢病毒干扰载体组建的慢病毒对人Hep G2细胞分化抑制蛋白1(Id1)基因的沉默效应。方法构建4种针对Id1基因不同干扰靶点的Id1-si RNA慢病毒干扰载体(p CGSIL-GFPId1-1、p CGSIL-GFP-Id1-2、p CGSIL-GFP-Id1-3及p CGSIL-GFP-Id1-4),将其转染至293T细胞,以筛选出针对Id1基因的最有效的RNA干扰(RNAi)靶序列。再以沉默效果最优的干扰载体进一步构建慢病毒(Id1-RNAi-LV),感染人Hep G2细胞后,采用实时定量PCR法和Western blot法分别检测其Id1 m RNA及其蛋白的表达水平。结果与p CGSIL-GFP-Id1-1组、p CGSIL-GFP-Id1-2组及p CGSIL-GFP-Id1-3组比较,p CGSIL-GFP-Id1-4组的Id1蛋白表达水平最低(P<0.05),沉默效果最优。以p CGSIL-GFP-Id1-4干扰载体组建慢病毒后,测得慢病毒的病毒滴度为2.0×109 TU/m L。与空白对照组和阴性对照组比较,以组建的慢病毒感染人Hep G2细胞后,人Hep G2细胞中Id1m RNA及其蛋白的表达水平均降低(P<0.05)。结论本实验构建的特异性慢病毒可稳定地介导Id1基因的沉默。 Objective To construct the human small interfering RNA (siRNA) lentiviral vector who targeting inhibitor ofdifferentiation-1 (Id1) gene, and to detect its efficiency ofgene silence for the HepG2 cells. Methods The most effective RNA interference sequences was screened from 4 kinds of siRNA vectors targeting Idl gene (included pCGSIL-GFP-Id1-1, pCGSIL-GFP-Id1-2, pCGSIL-GFP-Id1-3, and pCGSIL-GFP-Id1-4), who was transfected to 293T cells. The selected siRNA vector was used to build lentiviral vector (Idl-RNAi-LV) and then infected human HepG2 cells, Then the expression levels of Id1 mRNA and its protein were detected by the real time PCR and Western blot method respectively. Results Expression level of Idl protein in pCGSIL-GFP-Id1-4 group was lower than those of pCGSIL-GFP-Id1-1 group, pCGSIL-GFP-Id1-2 group, and pCGSIL-GFP-Id1-3 group (P 〈 0.05), who had the best efficiency of gene silence. The Id1-siRNA lentiviral vector (Id1-RNAi-LV) was successfully constructed by using pCGSIL-GFP-Id1-4. The titer of lentiviral was 2.0 × 10^9 TU/mL. Results of real time-PCR and Western blot showed that, the expression levels of Idl mRNA and its protein in HepG2 cells of Id1-RNAi-LV group were lower than those of blank control group and negative control group (P〈0.05). Conclusions The specific lentiviral can constantly downregulate the expression ofld1 gene.
出处 《中国普外基础与临床杂志》 CAS 2014年第12期1511-1517,共7页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金青年项目(项目编号:81101818)~~
关键词 分化抑制蛋白1 慢病毒干扰载体 基因沉默 HEPG2细胞系 肝细胞肝癌 Inhibitor of differentiation- 1 Interference lentiviral vector Gene silence HepG2 cell line Hepato- cellular carcinoma
  • 相关文献

参考文献27

  • 1Kamangar F, Dores GM, Anderson WF. Pattems of cancer inci- dence, mortality, and prevalence across five continents : defining priorities to reduce cancer disparities in different geographic regions oftheworld [J]. J ClinOncol, 2006, 24(14): 2137-2150.
  • 2Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carci- noma [J]. Int J Exp Pathol, 2001, 82(2): 77-100.
  • 3Murakami S. Hepatitis B virus X protein: structure, function and biology [J]. Intervirology, 1999, 42(2-3): 81-99.
  • 4Murakami S. Hepatitis B virus X protein: a multi functional viral regulator [J]. J Gastroenterol, 2001,36(10): 651-660.
  • 5Benezra R, Davis RL, Lockshon D, et al. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins [J]. Cell, 1990, 61(1): 49-59.
  • 6Wong YC, Wang X, Ling MT. Id-1 expression and cell survival [J]. Apoptosis, 2004, 9(3): 279-289.
  • 7Schindl M, Schoppmann SF, Strebel T, et al. Level ofld-1 protein expression correlates with poor differentiation, enhanced malig- nant potential, and more aggressive clinical behavior of epithelial ovarian tumors [J]. Clin Cancer Res, 2003, 9(2): 779-785.
  • 8Ouyang XS, Wang X, Lee DT, et aL Over expression of ID- 1 in prostate cancer [J]. J Urol, 2002, 167(6): 2598-2602.
  • 9Schoppmann SF, Schindl M, Bayer G, et aL Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer [J]. Int J Cancer, 2003, 104(6): 677-682.
  • 10Schindl M, Oberhuber G, Obermair A, et aL Overexpression of Id-I protein is a marker for unfavorable prognosis in early-stage cervical cancer [J ]. Cancer Res, 2001, 61(15): 5703-5706.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部